Highlights From JNJ's Q1 Conference Call: U.S. Sales Declined by 0.6%; Total Worldwide Revenues Increased 3.5%
Go back to Highlights From JNJ's Q1 Conference Call: U.S. Sales Declined by 0.6%; Total Worldwide Revenues Increased 3.5%| Johnson & Johnson (NYSE: JNJ) | Delayed: 271.13 +3.76 (1.41%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $267.37 | 52 Week High | $126.07 | |||
| Open | $267.83 | 52 Week Low | $94.28 | |||
| Day High | $272.66 | P/E | 56.37 | |||
| Day Low | $267.00 | EPS | $4.81 | |||
| Volume | 1,517,285 | |||||
| Merck & Co. (NYSE: MRK) | Delayed: 153.53 +4.54 (3.05%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $148.99 | 52 Week High | $65.46 | |||
| Open | $149.12 | 52 Week Low | $47.97 | |||
| Day High | $154.49 | P/E | 104.44 | |||
| Day Low | $148.59 | EPS | $1.47 | |||
| Volume | 4,408,970 | |||||
